Skip to main content
Clinical Trials/NCT01949285
NCT01949285
Completed
Not Applicable

A Theranostic Tool to Assess and Enable Spared Spinal Motor Function After SCI

NeuroEnabling Technologies, Inc.1 site in 1 country10 target enrollmentJune 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spinal Cord Injury
Sponsor
NeuroEnabling Technologies, Inc.
Enrollment
10
Locations
1
Primary Endpoint
Improvement in sensorimotor function in the lower extremities
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study is to determine if non-invasive electrical stimulation of the spinal cord can be used to: 1) assess spared function following a spinal cord injury; and 2) be use for rehabilitation.

Detailed Description

This study is to determine if non-invasive electrical stimulation of the spinal cord can be used to: 1) assess spared function following a spinal cord injury; and 2) be use for rehabilitation. The investigators hypothesize that this type of stimulation can be used to locate and determine if any spinal (nerve) pathways or connections were spared following a spinal cord injury. We also hypothesize the same stimulation can help revive or recover function to muscles connected to these spared spinal (nerve) pathways in individuals who are clinically paralyzed. Our research has demonstrated that modifying the activation state of the spinal cord after an injury, or awakening the spinal cord, can benefit people with paralysis years after a spinal cord injury. This method and device have not yet been approved by the FDA for the treatment of paralysis and are under investigation. This study if successful will help provide further evidence that could be use to one day to gain FDA approval.

Registry
clinicaltrials.gov
Start Date
June 2015
End Date
December 31, 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • SCI ASIA A, B, C
  • Spinal cord injury 1 or more years prior
  • Non progressive cervical or thoracic SCI
  • Half of key muscles below neurological level having a motor score of less than 2/5
  • Ability to commit to home exercises and 16 week participation
  • Stable medical condition without cardiopulmonary disease or dysautonomia that would contraindicate participation in lower extremity rehabilitation or testing activities
  • Not dependent on ventilation support
  • No painful musculoskeletal dysfunction, unhealed fracture, pressure sore, or urinary tract infection that might interfere with lower extremity rehabilitation or testing activities
  • No clinically significant depression or ongoing drug abuse
  • Adequate social support network to be able to participate in weekly training and assessment sessions for the duration of the 16 week study period

Exclusion Criteria

  • Pregnancy
  • No functional segmental reflexes below the lesion

Outcomes

Primary Outcomes

Improvement in sensorimotor function in the lower extremities

Time Frame: 10-12 weeks

Subjects will be tested by several measures of sensory and motor function, as well as self assessments of spasticity, quality of life, and independence. These tests include: American Spinal Injury Association (ASIA) scoring system, Spinal Cord Independence Measure (SCIM), Ashworth Spasticity Scale, Penn Spasm Frequency, Visual Analog Scale (VAS) for Spasticity, Electromyographic (EMG) recordings, Joint angle (goniometer) measures, kinematic analysis.

Secondary Outcomes

  • Ability to stand independently(2-4 weeks)

Study Sites (1)

Loading locations...

Similar Trials